Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Graves' Orbitopathy: do not give it for granted.

Literature DB >> 30084099

Graves' Orbitopathy: do not give it for granted.

Jessica Sabatino¹, Simone Donati², Luigi Bartalena³.

Abstract

Entities: Disease

Keywords: Craniosynostosis; Graves’ Orbitopathy

Mesh：

Year: 2018 PMID： 30084099 DOI： 10.1007/s12020-018-1710-5

Source DB: PubMed Journal: Endocrine ISSN： 1355-008X Impact factor: 3.633

× No keyword cloud information.

2 in total

Review 1. Craniosynostosis.

Authors: Lance S Governale
Journal: Pediatr Neurol Date: 2015-07-22 Impact factor: 3.372

Review 2. Extrathyroidal manifestations of Graves' disease: a 2014 update.

Authors: Luigi Bartalena; Vahab Fatourechi
Journal: J Endocrinol Invest Date: 2014-06-10 Impact factor: 4.256

2 in total

1 in total

1. Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of ¹³¹I during radioiodine therapy of Graves' disease.

Authors: C Happel; W T Kranert; D Gröner; J Baumgarten; J Halstenberg; B Bockisch; A Sabet; F Grünwald
Journal: Endocrine Date: 2021-01-13 Impact factor: 3.633

1 in total

Graves' Orbitopathy: do not give it for granted.

Review 1. Craniosynostosis.

Review 2. Extrathyroidal manifestations of Graves' disease: a 2014 update.

1. Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves' disease.

1. Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of ¹³¹I during radioiodine therapy of Graves' disease.